Pfizer Accuses Expert Of Tainting Doctor Testimony
Pfizer Inc. is urging a federal court overseeing the multidistrict litigation over its alleged off-label promotion of epilepsy drug Neurontin to issue an order preventing plaintiffs' counsel and their experts from...To view the full article, register now.
Already a subscriber? Click here to view full article